JP Morgan analyst Alexia Quadrani downgrades Roblox (NYSE:RBLX) from Overweight to Neutral and lowers the price target from $53 to $35.
Assessing Biogen’s Performance Against Competitors In Biotechnology Industry
Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors…